Search

everythinglearnresearchcommunity

for

Search:↓

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Hair transplanting is a useful, often overlooked treatment for female pattern hair loss.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Common skin conditions can greatly affect a person's mental health and social life.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Finasteride effectively treats baldness but may cause sexual side effects.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.